MobiHealth News April 11, 2022
The new algorithm is able to assess a user’s heart rhythm when they are asleep or still.
This morning Fitbit landed FDA clearance for its long-awaited photoplethysmography atrial fibrillation (AFib) detection algorithm. The algorithm will be part of Fitbit’s new Irregular Heart Rhythm Notification feature, which was designed to alert users of potential AFib.
The technology is able to run passively on Fitbit wearables and assess heart rhythm when a person is sleeping or not moving. Users with suspected AFib will get a notification suggesting that they see a healthcare professional.
“When your heart beats, tiny blood vessels throughout your body expand and contract based on changes in blood volume,” the Fitbit team wrote in the blog announcing...
Today's Sponsors
Today's Sponsor